materials and methods research manuscript

If sex or gender analysis was not conducted, the rationale should be given. Discussion: implications of sex and gender differences in the results should be discussed.Results: data should be presented disaggregated by sex and gender.explanation of how sex of participants was defined should be stated, either based on self-report, assigned following external or internal examination of body characteristics, or through genetic testing or other means.If they were not taken into consideration, the rationale should be given. if sex and gender differences were taken into consideration for the design of the study these should be stated.Introduction: if sex and gender differences are expected in the results, these should be stated.

Title/abstract: it should be clear if the results can only be applied to one sex or gender.

Authors should ensure that the terms sex and gender are used correctly throughout the article.

Sex and gender equity in research: F1000Research endorses the SAGER guidelines for reporting sex and gender information in study design, data analyses and results. For further details about trial registration, see our editorial policies. The disclosure of results on such sites does not preclude the publication of articles reporting and/or analyzing the same datasets in F1000Research. We support the public disclosure of all clinical trial results (as mandated in the US FDA Amendments Act, 2007), for example on a public website, such as. If the data associated with your article relate to a clinical trial then the Trial Registration details must be provided: name of registry, registry number, registration date and URL of the trial in the registry database.

Any deviation from the original trial protocol must be explained in the article. The trial registration number and registration date must be included in the Methods section. We ask authors to include a copy of the original trial protocol and a completed CONSORT checklist and flow diagram as supporting files, which will be published alongside the article. For reporting of the intervention methodology itself, F1000Research endorses the TIDieR checklist, an extension of the CONSORT statement. Secondly, supply the location as well, as in Bio-Rad Laboratories, Hercules, California.Clinical Trials: Articles in F1000Research that report clinical trials must adhere to the CONSORT reporting guidelines. If you used a spectrophotometer, say whether it was a Beckman DU-640 scanning spectrophotometer, an Agilent 8453 diode array instrument, or whatever.Īpart from any technical issues, such details add credibility to your paper.Īlso, when you mention the names of companies, make sure that you use the correct name: for instance, the name of a well-known supplier of diagnostics is Bio-Rad Laboratories (not just Bio-Rad, and note also the hyphen and the capitals). For instance, if you have used an SEM (scanning electron microscope), you should state whether it was an Olympus Lext OLS3100 Confocalm or Philips XL 30 or a Hitachi S-3700N or whatever. Similarly, for any item of laboratory equipment or supplies that you mention in the materials and methods section, you should supply appropriate details, such as the make and model, name of the manufacturer and the company's location, and so on. The references section requires adequate details of the documents cited: for a paper in a journal, the name of the journal, volume number, and page numbers for a book, the place of publication and the publisher for a conference presentation, the title of the conference, dates, city/town, organizers, and so on.

Materials and methods research manuscript